Effect of ondansetron in the prevention of spinal anesthesia-induced hypotension

Background and Aims: Hypotension and bradycardia are the common side effects seen after spinal anesthesia. Multiple strategies are tested to prevent the postspinal anesthesia-induced hypotension. Recently, Ondansetron, a 5-HT3 antagonist commonly used as an antiemetic was found to be effective in p...

Full description

Bibliographic Details
Main Authors: K Raghu, Shishir Kumar, G Rajaram, N Nikhil, P Damodar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Journal of the Scientific Society
Subjects:
Online Access:http://www.jscisociety.com/article.asp?issn=0974-5009;year=2018;volume=45;issue=3;spage=125;epage=128;aulast=Raghu
id doaj-854e8f2653c74789aced2c2fe0c211d1
record_format Article
spelling doaj-854e8f2653c74789aced2c2fe0c211d12020-11-24T23:55:25ZengWolters Kluwer Medknow PublicationsJournal of the Scientific Society0974-50092018-01-0145312512810.4103/jss.JSS_45_18Effect of ondansetron in the prevention of spinal anesthesia-induced hypotensionK RaghuShishir KumarG RajaramN NikhilP DamodarBackground and Aims: Hypotension and bradycardia are the common side effects seen after spinal anesthesia. Multiple strategies are tested to prevent the postspinal anesthesia-induced hypotension. Recently, Ondansetron, a 5-HT3 antagonist commonly used as an antiemetic was found to be effective in preventing spinal anesthesia-induced hypotension. The aim of this study is to evaluate the effect of ondansetron in the prevention of spinal anesthesia-induced hypotension. Materials and Methods: A prospective, randomized, and double-blind study was conducted on 110 elderly patients, aged 50–70 years, of the American Society of Anesthesiologists Grade I or II category, scheduled for various surgeries under spinal anesthesia. The patients were randomly divided into two groups of 55 each to receive either ondansetron 8 mg (Group A) or saline (Group B) before spinal anesthesia. The primary outcome of the study was the incidence of hypotension (systolic blood pressure <100 mm Hg or fall >20% in the baseline values). Secondary outcomes, such as the requirement of ephedrine, the incidence of bradycardia, nausea, and vomiting were also recorded during the study. Results: Group A and Group B were comparable with respect to age, sex, height, and weight. Thirty-four patients in Group B (60.7%) and 22 patients in Group A developed hypotension (39.3%) (P = 0.0359) [Table 1]. The use of ephedrine was greater in Group B than that of Group A (mean 4.61 ± 1.80 vs. 3.45 ± 1.09, P = 0.0107). Thirteen patients in Group B and four patients in Group A had bradycardia (P = 0.0176). Nine patients in Group B and two patients in Group A had vomiting (P = 0.0261). Conclusion: We conclude that prophylactic administration of ondansetron is effective in reducing the incidence of spinal anesthesia-induced hypotension.http://www.jscisociety.com/article.asp?issn=0974-5009;year=2018;volume=45;issue=3;spage=125;epage=128;aulast=RaghuHypotensionondansetronspinal anesthesia
collection DOAJ
language English
format Article
sources DOAJ
author K Raghu
Shishir Kumar
G Rajaram
N Nikhil
P Damodar
spellingShingle K Raghu
Shishir Kumar
G Rajaram
N Nikhil
P Damodar
Effect of ondansetron in the prevention of spinal anesthesia-induced hypotension
Journal of the Scientific Society
Hypotension
ondansetron
spinal anesthesia
author_facet K Raghu
Shishir Kumar
G Rajaram
N Nikhil
P Damodar
author_sort K Raghu
title Effect of ondansetron in the prevention of spinal anesthesia-induced hypotension
title_short Effect of ondansetron in the prevention of spinal anesthesia-induced hypotension
title_full Effect of ondansetron in the prevention of spinal anesthesia-induced hypotension
title_fullStr Effect of ondansetron in the prevention of spinal anesthesia-induced hypotension
title_full_unstemmed Effect of ondansetron in the prevention of spinal anesthesia-induced hypotension
title_sort effect of ondansetron in the prevention of spinal anesthesia-induced hypotension
publisher Wolters Kluwer Medknow Publications
series Journal of the Scientific Society
issn 0974-5009
publishDate 2018-01-01
description Background and Aims: Hypotension and bradycardia are the common side effects seen after spinal anesthesia. Multiple strategies are tested to prevent the postspinal anesthesia-induced hypotension. Recently, Ondansetron, a 5-HT3 antagonist commonly used as an antiemetic was found to be effective in preventing spinal anesthesia-induced hypotension. The aim of this study is to evaluate the effect of ondansetron in the prevention of spinal anesthesia-induced hypotension. Materials and Methods: A prospective, randomized, and double-blind study was conducted on 110 elderly patients, aged 50–70 years, of the American Society of Anesthesiologists Grade I or II category, scheduled for various surgeries under spinal anesthesia. The patients were randomly divided into two groups of 55 each to receive either ondansetron 8 mg (Group A) or saline (Group B) before spinal anesthesia. The primary outcome of the study was the incidence of hypotension (systolic blood pressure <100 mm Hg or fall >20% in the baseline values). Secondary outcomes, such as the requirement of ephedrine, the incidence of bradycardia, nausea, and vomiting were also recorded during the study. Results: Group A and Group B were comparable with respect to age, sex, height, and weight. Thirty-four patients in Group B (60.7%) and 22 patients in Group A developed hypotension (39.3%) (P = 0.0359) [Table 1]. The use of ephedrine was greater in Group B than that of Group A (mean 4.61 ± 1.80 vs. 3.45 ± 1.09, P = 0.0107). Thirteen patients in Group B and four patients in Group A had bradycardia (P = 0.0176). Nine patients in Group B and two patients in Group A had vomiting (P = 0.0261). Conclusion: We conclude that prophylactic administration of ondansetron is effective in reducing the incidence of spinal anesthesia-induced hypotension.
topic Hypotension
ondansetron
spinal anesthesia
url http://www.jscisociety.com/article.asp?issn=0974-5009;year=2018;volume=45;issue=3;spage=125;epage=128;aulast=Raghu
work_keys_str_mv AT kraghu effectofondansetroninthepreventionofspinalanesthesiainducedhypotension
AT shishirkumar effectofondansetroninthepreventionofspinalanesthesiainducedhypotension
AT grajaram effectofondansetroninthepreventionofspinalanesthesiainducedhypotension
AT nnikhil effectofondansetroninthepreventionofspinalanesthesiainducedhypotension
AT pdamodar effectofondansetroninthepreventionofspinalanesthesiainducedhypotension
_version_ 1725462608568385536